SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-22-001510
Filing Date
2022-11-10
Accepted
2022-11-10 17:12:27
Documents
13
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e618010_8k-plx.htm   iXBRL 8-K 41602
2 e618010_ex99-1.htm EX-99.1 87920
  Complete submission text file 0001193805-22-001510.txt   320383

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE plxp-20221108.xsd EX-101.SCH 3230
4 XBRL LABEL FILE plxp-20221108_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE plxp-20221108_pre.xml EX-101.PRE 22791
7 EXTRACTED XBRL INSTANCE DOCUMENT e618010_8k-plx_htm.xml XML 3783
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 221378513
SIC: 2834 Pharmaceutical Preparations